Bright Green Corporation - BGXX Business Value

Brandmark of Bright Green Corporation (BGXX)

This daily price chart for Bright Green (BGXX) illustrates the company's valuation, which stands at . The business relies on large-scale legal plant cultivation in the US, adhering to DEA regulations to reduce raw material costs. Secure delivery to pharmacies ensures medication availability, while a total focus on the domestic market eliminates all international risks and sanctions.

brightgreen.us (BGXX) - Total Company Value from 07/04/2022 to 10/30/2026

Summary analytical data breakdowns for Bright Green Corporation (BGXX)

- price and consensus price forecast:
Price Rate Chart Bright Green Corp.|BGXX - Consensus Target
- issuer market value details:
Market Capitalization Bright Green|BGXX - Real Price to Acquire Entire Company
- balance sheet net asset value indicators:
Equity per Share Bright Green|BGXX - Company Book Value|Capitalization to Book Value Ratio brightgreen.us|BGXX - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital Bright Green|BGXX - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Bright Green Corp.|BGXX - Company Aggregate Debts|Debt to Book Value Bright Green|BGXX - Company Long-Term Debt|Short-Term Debt Bright Green|Intermediate Coverage Ratio brightgreen.us
- earnings and valuation multiples indicators:
BGXX - Net Profit
Summary company analytics:BGXX - Bright Green
Original product of Bright Green Corp

Bright Green (BGXX) faces risks regarding business predictability due to management's limited operational experience in scaling cultivations. An analysis of the current EV allows for the removal of speculation from the market value by summing the market capitalization with net debt to determine the actual acquisition price of the asset, which helps investors distinguish random price fluctuations from systemic changes in the issuer's financial stability.

Competitors of Bright Green (BGXX)

Full Takeover Company Value Indivior plc|COLL: Real Price to Acquire Entire Company|CRON (Cronos Corp) - Business Value|CGC (Canopy Growth) - Real Price to Acquire Entire Company|Business Value HITI|Total Company Value Aurora Cannabis, Inc.|Business Value ACHV (Achieve Life Sciences Inc.)|Enterprise Value SKYE|Enterprise Value Anebulo Pharma (ANEB)|Total Company Value InterCure INCR|Value Adjusted for Debt and Cash NTRB|Nasus Pharma, Ltd. - Enterprise Value|IGC Pharma, Inc. (IGC) - Real Price to Acquire Entire Company|mirapharmaceuticals.com (MIRA) - Total Company Value|Total Enterprise Value Flora Growth Inc (FLGC)|Real Price to Acquire Entire Company IMCC|ADIL: Value Adjusted for Debt and Cash|Enterprise Value ARTL|ENSC: Full Business Value|Enterprise Value TTNP (Titan Pharmaceuticals, Inc.)|Enterprise Value Greenlane Corp GNLN|INM - Total Company Value|Value Adjusted for Debt and Cash AKAN (akandacorp.com)|Enveric Biosciences, Inc. (ENVB) - Total Company Value|Real Price to Acquire Entire Company Hempacco Co Inc.